Safety and efficacy of SITAgliptin plus GRanulocyte-colony-stimulating factor in patients suffering from Acute Myocardial Infarction (SITAGRAMI-Trial)--rationale, design and first interim analysis (Q43201878)

From Wikidata
Jump to navigation Jump to search
scientific article published on 3 January 2010
edit
Language Label Description Also known as
English
Safety and efficacy of SITAgliptin plus GRanulocyte-colony-stimulating factor in patients suffering from Acute Myocardial Infarction (SITAGRAMI-Trial)--rationale, design and first interim analysis
scientific article published on 3 January 2010

    Statements

    Safety and efficacy of SITAgliptin plus GRanulocyte-colony-stimulating factor in patients suffering from Acute Myocardial Infarction (SITAGRAMI-Trial)--rationale, design and first interim analysis (English)
    Hans D Theiss
    Christoph Brenner
    Markus G Engelmann
    Marc-Michael Zaruba
    Bruno Huber
    Volkmar Henschel
    Ulrich Mansmann
    Gerhard Steinbeck
    Wolfgang-M Franz
    3 January 2010
    282-284

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit